Next Generation Sequencing Market was estimated to be USD 6.8 billion in 2022. It is projected to reach USD 32.7 billion by 2030, exhibiting a remarkable compound annual growth rate (CAGR) of 21.7% during the forecast period from 2023 to 2030.

NGS, a cutting-edge technology in the field of genetic analysis, has witnessed significant growth and is poised for even greater expansion in the coming years. This surge can be attributed to the increasing demand for personalized medicine, advancements in genomic research, and the rising prevalence of chronic diseases.

The remarkable growth trajectory of the NGS market is driven by several factors. Firstly, the growing adoption of NGS in clinical diagnostics and research applications has revolutionized the field of genomics. The ability of NGS to rapidly sequence large volumes of DNA has paved the way for more accurate and comprehensive analysis, enabling researchers and healthcare professionals to gain deeper insights into genetic variations and their implications on human health.

Furthermore, the declining costs associated with NGS technologies have made it more accessible to a wider range of users, including academic institutions, pharmaceutical companies, and clinical laboratories. This affordability factor has played a pivotal role in driving the market growth, as it has encouraged greater adoption and utilization of NGS in various sectors.

Moreover, the increasing prevalence of chronic diseases, such as cancer and genetic disorders, has created a pressing need for advanced diagnostic tools that can provide precise and personalized treatment options. NGS has emerged as a powerful tool in this regard, offering the potential to identify genetic mutations and variations that can guide targeted therapies and improve patient outcomes.

Geographically, North America currently dominates the NGS market, owing to the presence of well-established healthcare infrastructure, extensive research activities, and favorable government initiatives. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, driven by the increasing investments in healthcare infrastructure, rising awareness about personalized medicine.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/3720

KEY MARKET SEGMENTATION:

By Product

• Consumables
  • Sample Preparation
  • Target Enrichment
  • Others
• Platforms
  • Sequencing
  • Data Analysis

 By Technology

• WGS
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing
  • DNA-based
  • RNA-based

By Workflow

• Pre-Sequencing
  • NGS Library Preparation Kits
  • Semi-automated Library Preparation
  • Automated Library Preparation
• Sequencing
• NGS Data Analysis
  • NGS Primary Data Analysis
  • NGS Secondary Data Analysis
  • NGS Tertiary Data Analysis

By Application

• Oncology
  • Diagnostics and Screening
    • Oncology Screening
      • Sporadic Cancer
      • Inherited Cancer
    • Companion Diagnostics
    • Other Diagnostics
  • Research Studies
• Clinical Investigation
  • Infectious Diseases
  • Inherited Diseases
  • Idiopathic Diseases
  • Non-Communicable/Other Diseases
• ReProduct & Serviceive Health
  • NIPT
    • Aneuploidy
    • Microdeletions
  • PGT
    • Newborn Genetic Screening
    • Single Gene Analysis
  • HLA Typing/Immune System Monitoring
  • Metagenomics
  • Epidemiology & Drug Development
  • Agrigenomics & Forensics
  • Consumer Genomics

By End User

• Academic Research
• Clinical Research, Hospitals & Clinics
• Pharma & Biotech Entities
• Other Users

Major Players Listed in the Report are as Follows:

Illumina, F. Hoffman-La Roche Ltd., QIAGEN, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies, PierianDx, Genomatix GmbH, DNASTAR, Inc., Perkin Elmer, Inc., Eurofins GATC Biotech GmbH, BGI, and Others.

Other Reports You May Like:

Flow Cytometry Market

Image-guided Biopsy Market

Cholesterol Test Market

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com